Skip to main content

and
  1. No Access

    Article

    Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    Therapy for multiple myeloma (MM) has markedly changed in the past decade with the introduction of new drugs, but it is not clear whether the improvements have been sustained. We studied 1038 patients diagnose...

    S K Kumar, A Dispenzieri, M Q Lacy, M A Gertz, F K Buadi, S Pandey, P Kapoor in Leukemia (2014)

  2. Article

    Erratum: Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1β and NO lead to inactivation of caspases

    Correction to: Oncogene (2006) 25, 3973–3981. doi:10.1038/sj.onc.1209423 Since publication of the above manuscript, the authors have identified errors in Figure 6b and c. The revised version of the figure is g...

    S Sebens Müerköster, J Lust, A Arlt, R Häsler, M Witt, T Sebens, S Schreiber in Oncogene (2006)

  3. No Access

    Article

    Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1β and NO lead to inactivation of caspases

    Pancreatic cancer exhibits profound chemoresistance resulting either from pre-existing (intrinsic) mechanisms, or from anticancer drug treatment itself (acquired chemoresistance). To identify molecular alterat...

    S Sebens Müerköster, J Lust, A Arlt, R Häsler, M Witt, T Sebens, S Schreiber in Oncogene (2006)